Case definition
).
Neonatal (classical) CAH
Forty of the 55 confirmed cases were classical neonatal CAH (Figure 13 ), giving an incidence of 5.9/100,000 live births. Thirty-nine were due to 21-hydroxylase deficiency (21-OH def) and one to 3-beta hydroxysteroid dehydrogenase deficiency (3-beta HSD def). Eighteen were males. Table 17 shows the state of origin and sex distribution of these cases.
Late onset (non-classical) CAH
Fifteen cases of non-classical, late-onset CAH were identified ( Figure 13 ). Five (33%) were males. Fourteen were due to 21-hydroxylase deficiency and one to 3-beta hydroxysteroid dehydrogenase deficiency. Mean (SD) age at diagnosis was 7.3 (4.1) years. The bone age was advanced by a mean (SD) of 2.5 years (2.1) years. Cases of non-classical (late onset) CAH will be missed by APSU surveillance if they present to adult specialists.
Results of newborn screening
Between October 1995 and September 1997, newborn screening in NSW/ACT and APSU surveillance of CAH occurred simultaneously. During this period, 12 cases were confirmed from NSW/ACT, of which six (50%) were initially detected on newborn screening (Table 18 ). These included one female, who had no genital abnormalities and a relatively mild enzyme block and five males. Five other females with genital abnormalities, who were diagnosed clinically at birth, were subsequently found to be abnormal on newborn screening. One 
Conclusion
The incidence of classical (neonatal) CAH in Australia was estimated at 5.9/100,000. The pilot newborn screening program in NSW/ACT suggested that, by enabling early diagnosis, screening may reduce the severe morbidity and potential mortality associated with salt-wasting adrenal crises. It also allowed comparison of the two methods and demonstrated the method used by the APSU to have a high sensitivity for case ascertainment. National newborn screening will not be introduced until cheaper technology, which is currently under development, is available.
Data analysis from this study is incomplete and a final report will be included in the 1998 annual report. 
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